Azenta EBITDA Margin 2012-2025 | AZTA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Azenta (AZTA) over the last 10 years. The current EBITDA margin for Azenta as of December 31, 2025 is .
| Azenta EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-12-31 | $0.60B | $0.03B | 5.55% |
| 2025-09-30 | $0.59B | $0.03B | 5.56% |
| 2025-06-30 | $0.59B | $0.04B | 6.14% |
| 2025-03-31 | $0.59B | $0.15B | 25.77% |
| 2024-12-31 | $0.58B | $0.15B | 26.08% |
| 2024-09-30 | $0.57B | $0.15B | 26.18% |
| 2024-06-30 | $0.48B | $0.15B | 30.56% |
| 2024-03-31 | $0.50B | $0.02B | 4.37% |
| 2023-12-31 | $0.52B | $0.03B | 6.21% |
| 2023-09-30 | $0.55B | $0.02B | 2.90% |
| 2023-06-30 | $0.63B | $0.01B | 0.79% |
| 2023-03-31 | $0.60B | $0.00B | 0.34% |
| 2022-12-31 | $0.60B | $0.00B | 0.50% |
| 2022-09-30 | $0.56B | $0.03B | 4.85% |
| 2022-06-30 | $0.56B | $0.02B | 3.06% |
| 2022-03-31 | $0.55B | $0.03B | 5.80% |
| 2021-12-31 | $0.54B | $0.03B | 5.78% |
| 2021-09-30 | $0.51B | $0.03B | 6.61% |
| 2021-06-30 | $0.11B | $-0.03B | -22.81% |
| 2021-03-31 | $0.21B | $-0.01B | -2.93% |
| 2020-12-31 | $0.30B | $0.02B | 6.10% |
| 2020-09-30 | $0.39B | $0.03B | 7.47% |
| 2020-06-30 | $0.40B | $0.03B | 6.44% |
| 2020-03-31 | $0.39B | $0.02B | 5.41% |
| 2019-12-31 | $0.37B | $0.02B | 4.92% |
| 2019-09-30 | $0.33B | $0.01B | 2.40% |
| 2019-06-30 | $0.74B | $0.09B | 12.15% |
| 2019-03-31 | $0.71B | $0.08B | 11.57% |
| 2018-12-31 | $0.67B | $0.07B | 11.08% |
| 2018-09-30 | $0.63B | $0.07B | 11.23% |
| 2018-06-30 | $0.49B | $0.03B | 6.56% |
| 2018-03-31 | $0.50B | $0.04B | 7.03% |
| 2017-12-31 | $0.51B | $0.04B | 7.25% |
| 2017-09-30 | $0.53B | $0.04B | 8.16% |
| 2017-06-30 | $0.54B | $0.06B | 11.81% |
| 2017-03-31 | $0.51B | $0.05B | 10.63% |
| 2016-12-31 | $0.47B | $0.03B | 6.96% |
| 2016-09-30 | $0.43B | $0.01B | 2.53% |
| 2016-06-30 | $0.55B | $0.03B | 5.83% |
| 2016-03-31 | $0.55B | $0.03B | 6.04% |
| 2015-12-31 | $0.55B | $0.04B | 7.64% |
| 2015-09-30 | $0.55B | $0.04B | 7.96% |
| 2015-06-30 | $0.53B | $0.03B | 6.23% |
| 2015-03-31 | $0.50B | $0.02B | 3.19% |
| 2014-12-31 | $0.49B | $0.01B | 2.86% |
| 2014-09-30 | $0.48B | $0.02B | 4.35% |
| 2014-06-30 | $0.46B | $0.02B | 4.09% |
| 2014-03-31 | $0.46B | $0.03B | 5.90% |
| 2013-12-31 | $0.44B | $0.02B | 4.99% |
| 2013-09-30 | $0.42B | $0.01B | 2.13% |
| 2013-06-30 | $0.41B | $-0.01B | -1.47% |
| 2013-03-31 | $0.44B | $0.00B | 0.00% |
| 2012-12-31 | $0.47B | $0.01B | 2.36% |
| 2012-09-30 | $0.49B | $0.02B | 4.92% |
| 2012-06-30 | $0.53B | $0.05B | 9.06% |
| 2012-03-31 | $0.58B | $0.06B | 10.59% |
| 2011-12-31 | $0.63B | $0.08B | 12.38% |
| 2011-09-30 | $0.69B | $0.10B | 14.39% |
| 2011-06-30 | $0.74B | $0.11B | 15.43% |
| 2011-03-31 | $0.71B | $0.11B | 15.21% |
| 2010-12-31 | $0.67B | $0.09B | 13.83% |
| 2010-09-30 | $0.59B | $0.07B | 11.30% |
| 2010-06-30 | $0.48B | $-0.04B | -8.84% |
| 2010-03-31 | $0.36B | $-0.08B | -23.20% |
| 2009-12-31 | $0.25B | $-0.17B | -68.53% |
| 2009-09-30 | $0.22B | $-0.20B | -92.20% |
| 2009-06-30 | $0.26B | $-0.33B | -126.05% |
| 2009-03-31 | $0.34B | $-0.31B | -90.62% |
| 2008-12-31 | $0.45B | $-0.24B | -51.99% |
| 2008-09-30 | $0.53B | $-0.20B | -38.71% |
| 2008-06-30 | $0.59B | $0.01B | 1.19% |
| 2008-03-31 | $0.65B | $0.03B | 4.59% |
| 2007-12-31 | $0.70B | $0.05B | 7.57% |
| 2007-09-30 | $0.74B | $0.07B | 9.69% |
| 2007-06-30 | $0.76B | $0.09B | 11.80% |
| 2007-03-31 | $0.74B | $0.09B | 11.96% |
| 2006-12-31 | $0.69B | $0.08B | 11.16% |
| 2006-09-30 | $0.61B | $0.05B | 8.40% |
| 2006-06-30 | $0.52B | $0.03B | 5.35% |
| 2006-03-31 | $0.47B | $0.01B | 2.95% |
| 2005-12-31 | $0.45B | $0.01B | 1.32% |
| 2005-09-30 | $0.46B | $0.02B | 3.24% |
| 2005-06-30 | $0.52B | $0.04B | 8.05% |
| 2005-03-31 | $0.56B | $0.06B | 10.14% |
| 2004-12-31 | $0.57B | $0.07B | 11.56% |
| 2004-09-30 | $0.54B | $0.06B | 10.61% |
| 2004-06-30 | $0.45B | $-0.01B | -1.55% |
| 2004-03-31 | $0.38B | $-0.06B | -14.88% |
| 2003-12-31 | $0.34B | $-0.09B | -26.04% |
| 2003-09-30 | $0.34B | $-0.12B | -36.47% |
| 2003-06-30 | $0.37B | $-0.63B | -171.51% |
| 2003-03-31 | $0.37B | $-0.62B | -170.03% |
| 2002-12-31 | $0.33B | $-0.62B | -187.01% |
| 2002-09-30 | $0.30B | $-0.59B | -193.75% |
| 2002-06-30 | $0.26B | $-0.08B | -31.18% |
| 2002-03-31 | $0.27B | $-0.05B | -16.79% |
| 2001-12-31 | $0.33B | $-0.02B | -6.69% |
| 2001-09-30 | $0.38B | $0.00B | 0.52% |
| 2001-06-30 | $0.42B | $0.04B | 10.02% |
| 2001-03-31 | $0.41B | $0.05B | 10.98% |
| 2000-12-31 | $0.38B | $0.05B | 12.17% |
| 2000-09-30 | $0.32B | $0.04B | 11.67% |
| 2000-06-30 | $0.26B | $0.06B | 21.48% |
| 2000-03-31 | $0.20B | $0.05B | 24.37% |
| 1999-12-31 | $0.14B | $0.02B | 11.35% |
| 1999-09-30 | $0.11B | $0.01B | 9.01% |
| 1999-06-30 | $0.09B | $0.01B | 11.70% |
| 1999-03-31 | $0.09B | $0.01B | 9.89% |
| 1998-12-31 | $0.09B | $0.03B | 27.47% |
| 1998-09-30 | $0.10B | $0.05B | 53.47% |
| 1998-06-30 | $0.12B | $0.09B | 73.28% |
| 1998-03-31 | $0.11B | $0.08B | 74.34% |
| 1997-12-31 | $0.11B | $0.09B | 81.90% |
| 1997-09-30 | $0.09B | $0.06B | 62.64% |
| 1997-06-30 | $0.08B | $0.01B | 8.86% |
| 1997-03-31 | $0.08B | $0.01B | 11.11% |
| 1996-12-31 | $0.09B | $0.01B | 14.77% |
| 1996-09-30 | $0.09B | $0.02B | 16.85% |
| 1996-06-30 | $0.08B | $0.03B | 34.57% |
| 1996-03-31 | $0.07B | $0.03B | 38.57% |
| 1995-12-31 | $0.06B | $0.03B | 46.55% |
| 1995-09-30 | $0.05B | $0.03B | 65.31% |
| 1995-06-30 | $0.04B | $0.02B | 53.66% |
| 1995-03-31 | $0.03B | $0.03B | 76.47% |
| 1994-12-31 | $0.03B | $0.03B | 100.00% |
| 1994-09-30 | $0.02B | $0.02B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.318B | $0.594B |
| Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $28.621B | 33.10 |
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Doximity (DOCS) | United States | $4.621B | 20.02 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.18 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Enovis (ENOV) | United States | $1.245B | 6.54 |
| Clover Health Investments (CLOV) | United States | $1.044B | 0.00 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.724B | 0.00 |
| Phreesia (PHR) | United States | $0.720B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |